Debt-to-equity of Lucid Diagnostics Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Lucid Diagnostics Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
Lucid Diagnostics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 361%, a 37% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Lucid Diagnostics Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	361%	+97%	+37%	30 Sep 2025
Q2 2025	778%	+427%	+122%	30 Jun 2025
Q1 2025	438%	+42%	+11%	31 Mar 2025
Q4 2024	202%	-77%	-28%	31 Dec 2024
Q3 2024	264%	+124%	+88%	30 Sep 2024
Q2 2024	351%	+271%	+341%	30 Jun 2024
Q1 2024	396%	+348%	+725%	31 Mar 2024
Q4 2023	278%	+244%	+724%	31 Dec 2023
Q3 2023	140%	+116%	+480%	30 Sep 2023
Q2 2023	79%	+30%	+60%	30 Jun 2023
Q1 2023	48%			31 Mar 2023
Q4 2022	34%			31 Dec 2022
Q3 2022	24%			30 Sep 2022
Q2 2022	50%			30 Jun 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.